The main market for pharmaceutical grade salt lies in dialysis solutions. Supply has struggled to keep up with demand, which led to AkzoNobel expanding its production site in Denmark.
AkzoNobel's Specialty Chemicals business completed the expansion of its production site, which supplies pharmaceutical grade salt to the healthcare industry, increasing capacity by 60%.
Located in Mariager, the products supplied by the facility are used as an active pharmaceutical ingredient in various applications, including intravenous solutions, insulin and baby food.
"Our facility produces the purest salt in the world," said Nils van der Plas, General Manager of AkzoNobel's Salt business, “this expansion will now enable us to serve a strong growing market worldwide.
“Following a year of detailed engineering, construction and testing, the Mariager site is now well positioned to continue capturing the organic dialysis market developments. This specific market is growing globally by 7 to 8% per year and is expected to continue growing at this pace for at least another generation."
In addition to dialysis, pharmaceutical grade salt is also used as a base material for liquid medications and dietary formulations.
